Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03685461 · ClinicalTrials.gov registry record · NA
AB-Intra- and Post-Operative Measures of Auditory Function
A NA study of Hearing Loss and Cochlear Implant, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT03685461: Completed NA study of Hearing Loss and Cochlear Implant, sponsored by Medical College of Wisconsin.
NCT03685461 is a NA study of Hearing Loss and Cochlear Implant that has completed, run by Medical College of Wisconsin. The registered enrollment target is 88 participants, below the 6,119-participant average among 58 other Hearing Loss trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03685461, a NA study of Hearing Loss and Cochlear Implant, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see how the inner ear responds to sound delivered to the ear canal during and after your cochlear implant surgery. This information may be helpful in telling us how well a cochlear implant performs after surgery.
Primary Outcome
Following cochlear implant surgery a CT scan, optimized for resolution of the CI electrode, will be obtained. This will be merged with routine clinically acquired pre-operative imaging to determine which of the scala the electrode sides in and whether or not there has been any translocation from one scala into another.
Conditions Studied
Interventions
- OTHER Electrocochleography
Study Locations (1)
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
What the finished NCT03685461 record still lists
NCT03685461 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 6,119-participant average among 58 other Hearing Loss trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which Electrocochleography is the first listed.
NCT03685461 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03685461 about?
NCT03685461 is a clinical study titled "AB-Intra- and Post-Operative Measures of Auditory Function". The purpose of this study is to see how the inner ear responds to sound delivered to the ear canal during and after your cochlear implant surgery. This information may be helpful in telling us how well a cochlear implant performs after surgery.
What is the current status of trial NCT03685461?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2018-10-01. Estimated completion is 2025-12-01.
What conditions does trial NCT03685461 study?
This clinical trial studies the following conditions: Hearing Loss, Cochlear Implant.
What interventions are being tested in trial NCT03685461?
The interventions under investigation include: Electrocochleography (OTHER).
Who is sponsoring clinical trial NCT03685461?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03685461 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03685461's enrollment target sits among peer trials
88 33rd of 58 higher than 26 of 58 other Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Access and Affordability of Adult Hearing Healthcare
RECRUITING · NA
-
AI Noise Reduction in Phonak Hearing Aids
RECRUITING · NA
-
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Innovations in Hearing Accessibility and Technology (IHAT) Study
RECRUITING · NA
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI